bullish

Resapp Health

ResApp’s Confirmatory Study Fails, Resulting in Pfizer’s Lower A$0.146 Offer

570 Views21 Jun 2022 11:28
The revised SID provides no obvious way for Pfizer to pull its offer. At the last close of A$0.125, the gross spread to the unconfirmed data offer price of A$0.146 is 16.8%.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x